Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Cancer Gene Therapy|November 21, 1998
Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunityD C Saffran, H M Horton, M A Yankauckas, et al.Journal of Pharmaceutical Sciences|December 1, 1996
DNA vaccines against malaria: immunogenicity and protection in a rodent modelM J Gardner, D L Doolan, R C Hedstrom, et al.Vaccine|June 1, 1997
Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human useS L Hoffman, D L Doolan, M Sedegah, et al.Cancer Gene Therapy|May 1, 1996
Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivoS E Parker, S Khatibi, M Margalith, et al.Immunology and Cell Biology|August 1, 1997
Toward clinical trials of DNA vaccines against malariaS L Hoffman, D L Doolan, M Sedegah, et al.Proceedings of the National Academy of Sciences of the United States of America|September 3, 2004
A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax sporesG Hermanson, V Whitlow, S Parker, et al.International Journal of Molecular Medicine|December 17, 1998
In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccinesR C Hedstrom, D L Doolan, R Wang, et al.Gene Therapy|July 5, 2001
Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccineS E Parker, D Monteith, H Horton, et al.Infection and Immunity|August 26, 1998
Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmidsR Wang, D L Doolan, Y Charoenvit, et al.Vaccine|March 4, 2000
Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteersT P Le, K M Coonan, R C Hedstrom, et al.Pageof 4